Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
430.14
+4.13 (0.97%)
At close: Apr 28, 2026, 4:00 PM EDT
428.13
-2.01 (-0.47%)
After-hours: Apr 28, 2026, 7:57 PM EDT
Vertex Pharmaceuticals Analyst Ratings
Total Analysts
29
Consensus Rating
Buy
Price Target
$539.69
Upside
+25.47%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $596 → $612 | Buy | Maintains | $596 → $612 | +42.28% | Apr 10, 2026 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $575 | Hold → Strong Buy | Upgrades | $575 | +33.68% | Mar 18, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $490 → $525 | Strong Buy | Maintains | $490 → $525 | +22.05% | Mar 11, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $570 → $596 | Buy | Maintains | $570 → $596 | +38.56% | Mar 10, 2026 |
| B of A Securities | B of A Securities | Strong Buy Maintains $571 → $598 | Strong Buy | Maintains | $571 → $598 | +39.02% | Mar 10, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $575 → $585 | Strong Buy | Maintains | $575 → $585 | +36.00% | Mar 10, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $540 → $600 | Buy | Maintains | $540 → $600 | +39.49% | Mar 10, 2026 |
| Jefferies | Jefferies | Strong Buy Initiates $580 | Strong Buy | Initiates | $580 | +34.84% | Mar 10, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $591 → $641 | Strong Buy | Maintains | $591 → $641 | +49.02% | Mar 10, 2026 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $411 → $441 | Hold | Maintains | $411 → $441 | +2.52% | Feb 17, 2026 |
| Barclays | Barclays | Buy Maintains $606 → $607 | Buy | Maintains | $606 → $607 | +41.12% | Feb 17, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $518 → $591 | Strong Buy | Maintains | $518 → $591 | +37.40% | Feb 17, 2026 |
| Scotiabank | Scotiabank | Hold Maintains $495 → $558 | Hold | Maintains | $495 → $558 | +29.73% | Feb 13, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $546 → $541 | Buy | Maintains | $546 → $541 | +25.77% | Feb 13, 2026 |
| Stifel | Stifel | Hold Maintains $445 → $466 | Hold | Maintains | $445 → $466 | +8.34% | Feb 13, 2026 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $540 | Hold → Buy | Upgrades | $540 | +25.54% | Feb 13, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.